Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65.9M
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
9.9M
-
Shares change
-
+992K
-
Total reported value, excl. options
-
$76.5M
-
Value change
-
+$8.99M
-
Put/Call ratio
-
1.37
-
Number of buys
-
46
-
Number of sells
-
-29
-
Price
-
$7.73
Significant Holders of Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) as of Q1 2020
93 filings reported holding CTSO - Cytosorbents Corp - Common Stock, par value $0.001 per share as of Q1 2020.
Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.9M shares
of 65.9M outstanding shares and own 15.03% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.1M shares), VANGUARD GROUP INC (1.41M shares), Skylands Capital, LLC (1.13M shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (691K shares), STATE STREET CORP (539K shares), Sargent Investment Group, LLC (472K shares), GEODE CAPITAL MANAGEMENT, LLC (422K shares), NORTHERN TRUST CORP (349K shares), MORGAN STANLEY (263K shares), and RAYMOND JAMES & ASSOCIATES (220K shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.